|
|
| November 8, 2011: Dr. Clemens von Birgelen and Dr. C. Michael Gibson discuss: TWENTE |
Dr. Clemens von Birgelen and Dr. C. Michael Gibson discuss: TWENTE: A Prospective,
Randomized Trial of Zotarolimus-Eluting Stents and Everolimus-Eluting Stents in Patients
with Coronary Artery Disease
Dr. von Birgelen is a consultant to and has received speakers honoraria and/or travel
expenses from:
Abbott Vascular, Medtronic, and Boston Scientific
[ Download video ] |
|
No comments have been submitted
|